Aliana Guerrieri Gonzaga

Istituto Europeo di Oncologia

Research Interests

Explore related searches

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

Articles (23)

Collaborators (8)

Lucio Bertario

Fondazione IRCCS Istituto Nazionale dei Tumori

irene feroce

European Institute of Oncology

Giovanni Corso

University of Milan

Alessandra Stefania Rizzuto

University of Milan

Bjørn-Erik Bertelsen

Haukeland University Hospital

Mariarosaria Calvello

European Institute of Oncology

Massimiliano Ruscica

Associate Professor of General Pathology

Università degli Studi di Torino

Laura Cortesi

University of Modena and Reggio Emilia

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Aliana Guerrieri Gonzaga

Research Interests

Explore related searches

Contact this professor

Articles (23)

Collaborators (8)

Lucio Bertario

irene feroce

Giovanni Corso

Alessandra Stefania Rizzuto

Bjørn-Erik Bertelsen

Mariarosaria Calvello

Massimiliano Ruscica

Laura Cortesi

Make your next move.

Aliana Guerrieri Gonzaga

Research Interests

Explore related searches

Contact this professor

Articles (23)

Impact of Epigenome-Wide Methylation and Breast Cancer Recurrence in Women Tested Negative for BRCA Genes: The Breast Methylation Risk (BREMERI) Study

Effect of low-dose tamoxifen on benign gynecological and breast conditions in a phase 3 trial in noninvasive breast cancer

Window-of-opportunity trials to screen effective agents and optimize dose in breast cancer prevention

Predictive Effect of IGFBP-3 on Low-Dose Tamoxifen Efficacy in Noninvasive Breast Cancer in the Phase III Tam-01 Trial

Germline Testing in Breast Cancer: A Single-Center Analysis Comparing Strengths and Challenges of Different Approaches

Hereditary Breast Cancer: Comprehensive Risk Assessment and Prevention Strategies

Fenretinide in Young Women at Genetic or Familial Risk of Breast Cancer: A Placebo-Controlled Biomarker Trial

Prognostic Value of PCSK9 Levels in Premenopausal Women at Risk of Breast Cancer—Evidence from a 17-Year Follow-Up Study

Effect of metformin and lifestyle intervention on adipokines and hormones in breast cancer survivors: a pooled analysis from two randomized controlled trials.

Alternative dosing regimen of exemestane in a randomized presurgical trial: the role of obesity in biomarker modulation

Low dose TamOxifen and LifestylE changes for bReast cANcer prevention (TOLERANT study): Study protocol of a randomized phase II biomarker trial in women at increased risk for breast cancer

A Mediation Analysis of Obesity and Adiponectin Association with Postmenopausal Breast Cancer Risk: A Nested Cohort Study in the International Breast Cancer Intervention Study II (IBIS-II) Prevention Trial

Expression of immune-related genes and breast cancer recurrence in women with ductal carcinoma in situ

Germline pathogenic variants in metaplastic breast cancer patients and the emerging role of the BRCA1 gene

Hereditary Gastric Cancer: Single-Gene or Multigene Panel Testing? A Mono-Institutional Experience

Vitamin D Supplementation and Adherence to World Cancer Research Fund (WCRF) Diet Recommendations for Colorectal Cancer Prevention: A Nested Prospective Cohort Study of a Phase II Randomized Trial

Randomized Placebo Controlled Trial of Low-Dose Tamoxifen to Prevent Recurrence in Breast Noninvasive Neoplasia: A 10-Year Follow-Up of TAM-01 Study

Efficacy of Alternative Dose Regimens of Exemestane in Postmenopausal Women With Stage 0 to II Estrogen Receptor-Positive Breast Cancer: A Randomized Clinical Trial.

Prognostic impact of germline BRCA1/2 pathogenic variants in breast cancer.

Colorectal cancer, Vitamin D and microbiota: A double-blind Phase II randomized trial (ColoViD) in colorectal cancer patients.

Association of Vitamin D Receptor and Vitamin D-Binding Protein Polymorphisms with Familial Breast Cancer Prognosis in a Mono-Institutional Cohort

Microsatellite instability evaluation: which test to use for endometrial cancer?

Effect Modifiers of Low-Dose Tamoxifen in a Randomized Trial in Breast Noninvasive Disease

Collaborators (8)

Lucio Bertario

irene feroce

Giovanni Corso

Alessandra Stefania Rizzuto

Bjørn-Erik Bertelsen

Mariarosaria Calvello

Massimiliano Ruscica

Laura Cortesi

Make your next move.